148 related articles for article (PubMed ID: 34988031)
1. Corrigendum: Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway.
Jain AS; Prasad A; Pradeep S; Dharmashekar C; Achar RR; Silina E; Stupin V; Amachawadi RG; Prasad SK; Pruthvish R; Syed A; Shivamallu C; Kollur SP
Front Oncol; 2021; 11():822865. PubMed ID: 34988031
[TBL] [Abstract][Full Text] [Related]
2. Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway.
Jain AS; Prasad A; Pradeep S; Dharmashekar C; Achar RR; Ekaterina S; Victor S; Amachawadi RG; Prasad SK; Pruthvish R; Syed A; Shivamallu C; Kollur SP
Front Oncol; 2021; 11():741326. PubMed ID: 34692523
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Decreased DUSP26 Expression Promotes Malignant Behavior in Glioblastoma Cells
Chen J; Zeng Y; Wu R; Xuan Y; Jiang M; Teng H
Front Oncol; 2021; 11():676647. PubMed ID: 33928040
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer.
Peng Y; Li Z; Fu Y; Pan Y; Zeng Y; Liu J; Xiao C; Zhang Y; Su Y; Li G; Wu F
Front Oncol; 2023; 13():1163376. PubMed ID: 37064096
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Machine learning in non-small cell lung cancer radiotherapy: a bibliometric analysis.
Zhang J; Zhu H; Wang J; Chen Y; Li Y; Chen X; Chen M; Cai Z; Liu W
Front Oncol; 2023; 13():1197217. PubMed ID: 37143938
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors.
Hou T; Jiang S; Wang Y; Xie Y; Zhang H; Feng Y; Ma F; Ma J; Liu X; Hu C
Front Oncol; 2021; 11():705406. PubMed ID: 34150669
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study.
Dong D; Zhang S; Jiang B; Wei W; Wang C; Yang Q; Yan T; Chen M; Zheng L; Shao W; Xiong G
Front Oncol; 2023; 13():1275851. PubMed ID: 37692845
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Predicting Outcomes From Radical Radiotherapy for Non-small Cell Lung Cancer: A Systematic Review of the Existing Literature.
Walls GM; Hanna GG; Qi F; Zhao S; Xia J; Ansari MT; Landau D
Front Oncol; 2019; 9():112. PubMed ID: 30881918
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: Network Crosstalk as a Basis for Drug Repurposing.
Guala D; Sonnhammer ELL
Front Genet; 2022; 13():921286. PubMed ID: 35656321
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy.
Titmarsh HF; O'Connor R; Dhaliwal K; Akram AR
Front Oncol; 2020; 10():1516. PubMed ID: 32974185
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study.
Awad MM; Le Bruchec Y; Lu B; Ye J; Miller JA; Lizotte PH; Cavanaugh ME; Rode AJ; Dumitru CD; Spira A
Front Oncol; 2022; 12():889996. PubMed ID: 35747830
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: The
Bian X; Wang X; Zhang Q; Ma L; Cao G; Xu A; Han J; Huang J; Lin W
Front Oncol; 2023; 13():1192526. PubMed ID: 37124537
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor Receptor Mutation (G719A) Identified in the Cerebrospinal Fluid.
Ma C; Huang C; Tang D; Ye X; Li Z; Liu R; Mu N; Li J; Jiang R; Zhang J
Front Oncol; 2019; 9():938. PubMed ID: 31641649
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway.
Wei X; Shi J; Lin Q; Ma X; Pang Y; Mao H; Li R; Lu W; Wang Y; Liu P
Front Oncol; 2021; 11():742374. PubMed ID: 34557417
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis.
Zhang W; Wang W; Wu J; Tian J; Yan W; Yuan Y; Yao Y; Shang A; Quan W
Front Oncol; 2022; 12():1118042. PubMed ID: 36591456
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: Gastric Cancer Cell-Derived Exosomal MicroRNA-23a Promotes Angiogenesis by Targeting PTEN.
Du J; Liang Y; Li J; Zhao JM; Lin XY
Front Oncol; 2021; 11():797657. PubMed ID: 35127509
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: A Non-invasive Method to Diagnose Lung Adenocarcinoma.
Yan M; Wang W
Front Oncol; 2020; 10():1515. PubMed ID: 32983996
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines.
Yuan B; Xu K; Shimada R; Li J; Hayashi H; Okazaki M; Takagi N
Front Oncol; 2021; 11():778834. PubMed ID: 34692557
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Construction and Validation of a Lung Cancer Risk Prediction Model for Non-Smokers in China.
Guo LW; Lyu ZY; Meng QC; Zheng LY; Chen Q; Liu Y; Xu HF; Kang RH; Zhang LY; Cao XQ; Liu SZ; Sun XB; Zhang JG; Zhang SK
Front Oncol; 2022; 12():871848. PubMed ID: 35311146
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case report.
Zhang Z; Li Y; Dong Y; Li J; Zhang B; Zhang C; Cui X
Front Oncol; 2022; 12():980842. PubMed ID: 36033531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
